Norges Bank
MRVI icon

Norges Bank’s Maravai LifeSciences MRVI Stock Holding History

Norges Bank’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.54M Buy
+567,400
New +$2.45M ﹤0.01% 1428
2024
Q1 		– Sell
-299,380
Closed -$1.96M – 1943
2023
Q4 		$1.96M Hold
299,380
– – ﹤0.01% 1796
2023
Q3 		$2.99M Sell
299,380
-248,756
-45% -$2.73M ﹤0.01% 1775
2023
Q2 		$6.81M Sell
548,136
-355,624
-39% -$4.8M ﹤0.01% 1641
2023
Q1 		$12.7M Sell
903,760
-1,053,639
-54% -$15.1M ﹤0.01% 1484
2022
Q4 		$28M Buy
1,957,399
+579,860
+42% +$9.13M 0.01% 1115
2022
Q3 		$35.2M Buy
1,377,539
+349,715
+34% +$8.78M 0.01% 927
2022
Q2 		$29.2M Buy
1,027,824
+96,095
+10% +$3.04M 0.01% 1048
2022
Q1 		$32.9M Hold
931,729
– – 0.01% 1111
2021
Q4 		$39M Buy
931,729
+95,149
+11% +$3.85M 0.01% 1083
2021
Q3 		$41.1M Buy
836,580
+215,799
+35% +$10.5M 0.01% 1025
2021
Q2 		$25.9M Buy
+620,781
New +$24.1M 0.01% 1382
2021
Q1 		– Sell
-77,418
Closed -$2.17M – 2175
2020
Q4 		$2.17M Buy
+77,418
New +$2.16M ﹤0.01% 1945

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Norges Bank's MRVI Position: Q2 2026 in Review

Norges Bank opened a new position in Maravai LifeSciences (MRVI) in Q2 2026: 567,400 shares worth $3.54M. The stake represents ﹤0.01% of the portfolio and ranks #1428 among its holdings. This is a return to the name: Norges Bank previously reported a position in MRVI as recently as Q4 2023.

Norges Bank first reported a position in MRVI in Q4 2020 and has held it in 13 quarters since. The position peaked at $41.1M in Q3 2021. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • Norges Bank held 567,400 shares of Maravai LifeSciences worth $3.54M as of Q2 2026.
  • Maravai LifeSciences was a new Norges Bank position in Q2 2026.
  • Maravai LifeSciences made up ﹤0.01% of Norges Bank's portfolio in Q2 2026, its #1428 holding.
  • Norges Bank first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 13 quarters since.
  • Norges Bank's Maravai LifeSciences position peaked at $41.1M in Q3 2021.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Norges Bank's 13F filing for Q2 2026, filed 12 Aug 2026.